parthenolide and cyclin d1

parthenolide has been researched along with cyclin d1 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Crooks, PA; Nakshatri, H; Neelakantan, S; Noble, S; Ralstin, M; Schmidt, CM; Sweeney, CJ; Wu, H; Yiannoutsos, C; Yip-Schneider, MT1
Cheng, G; Xie, L1
Bai, S; Lu, J; Sheng, G; Wang, C; Wang, L; Wang, Y1
Aviles-Vazquez, S; Ayala-Sanchez, M; Chávez-González, A; Crooks, PA; Flores-Lopez, G; Guzman, ML; Mayani, H; Moreno-Lorenzana, D; Torres-Martinez, H1
Cao, Y; Li, Y; Liu, D; Liu, M; Yang, Y1
Cui, Q; Gu, W; Li, D; Li, Y; Pan, Z; Tan, X; Wang, X; Wu, S; Xu, H; Yang, L1

Other Studies

6 other study(ies) available for parthenolide and cyclin d1

ArticleYear
Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclin D1; Humans; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Prostaglandin-Endoperoxide Synthases; Sesquiterpenes; Sulindac

2007
Parthenolide induces apoptosis and cell cycle arrest of human 5637 bladder cancer cells in vitro.
    Molecules (Basel, Switzerland), 2011, Aug-09, Volume: 16, Issue:8

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 2; Diffusion Chambers, Culture; Flow Cytometry; G1 Phase; Humans; Microscopy; Neoplasm Invasiveness; Phosphorylation; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Signal Transduction; Tanacetum parthenium; Urinary Bladder Neoplasms

2011
Combined effects of FLT3 and NF-κB selective inhibitors on acute myeloid leukemia in vivo.
    Journal of biochemical and molecular toxicology, 2012, Volume: 26, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Line, Tumor; Cyclin D1; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Nuclear Receptor Co-Repressor 2; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Thiophenes; Tumor Burden; Xenograft Model Antitumor Assays

2012
Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species.
    Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:10

    Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin D1; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Recurrence, Local; NF-kappa B; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction

2018
Parthenolide increases the sensitivity of gastric cancer cells to chemotherapy.
    Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2020, Volume: 40, Issue:6

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin D1; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Stomach Neoplasms

2020
Parthenolide inhibits proliferation of cells infected with Kaposi's sarcoma-associated herpesvirus by suppression of the NF-κB signaling pathway.
    Archives of virology, 2023, Jan-07, Volume: 168, Issue:2

    Topics: Cell Proliferation; Cyclin D1; Herpesvirus 8, Human; Humans; I-kappa B Kinase; Neuroblastoma; NF-kappa B; RNA, Messenger; Sarcoma, Kaposi; Signal Transduction

2023